The most common (> 20%) adverse reactions, including laboratory abnormalities, with Larotrectinib were increased AST, increased ALT, anemia musculoskeletal pain, fatigue, hypoalbuminemia, neutropenia, increased alkaline phosphatase, cough, leukopenia, constipation, diarrhea, dizziness, hypocalcemia, nausea, vomiting, pyrexia, lymphopenia, and abdominal pain.
from FDA,2022.11
The tropomyosin receptor kinase (TRK) fusion protein produced by the fusion of the neurotrophic tyrosine receptor kinase (NTRK) gene is a major oncogenic driver that is rare in a v···【more】
Article source:Lucius LaosRelease date:2024-11-19Recommended:121
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: